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 In this study, Peptide Nucleic Acids (PNA) and PNA-DNA chimeras carrying thiol 
groups were used for surface functionalization of gold nanoparticles. Conjugation of 
PNA to citrate stabilized gold nanoparticles destabilized the nanoparticles causing them 
to precipitate. Addition of a tail of glutamic acid to the PNA prevented destabilisation 
of the nanoparticles but resulted in loss of interaction with complementary sequences. 
Importantly, PNA-DNA chimeras gave stable conjugates with gold nanoparticles. The 
hybridisation and melting properties of complexes formed from chimera-nanoparticle 
conjugates and oligonucleotide-nanoparticle conjugates are described for first time. 
Similar to oligonucleotide-nanoparticle conjugates, conjugates with PNA-DNA 
chimeras gave sharper and more defined melting profiles than those obtained using 
unmodified oligonucleotides. In addition, mismatch discrimination was found to be 
more efficient than with unmodified oligonucleotides 
 
Introduction.- Oligonucleotide bearing gold nanoparticles were first described in 
1996 [1, 2]. These conjugates have been shown to form periodic arrays [1, 3, 4] and to 
form predetermined dimeric and trimeric assemblies [2, 5]. The special properties of 
gold nanoparticles linked to oligonucleotides has attracted large interest due to their 
potential use in gene analysis [6-12].  
Peptide nucleic acids (PNA) are oligonucleotide analogues in which the negatively 
charged sugar-phosphate backbone has been replaced by a neutral backbone of N-(2-
aminoethyl)glycine units with the common nucleic acid bases attached via a carbonyl 
methylene linker [13]. PNA oligomers recognize and bind to a specific DNA or RNA 
strand with high affinity and selectivity [14, 15]. Their chemical stability and their 
resistance to nucleases and proteases make PNA oligomers good candidates as 
therapeutic agents, diagnostic tools and probes in molecular biology [15]. The addition 
of a PNA part to DNA to form PNA-DNA chimeras results in new structures which 
have combined properties from PNA and DNA. They show improve aqueous solubility 
due to the partially negatively charged backbone and they bind exclusively in the 
antiparallel orientation as DNA [16]. 
There is a large interest in the field of DNA derivatives as scaffolds for 
nanomaterials which have the same recognition properties as natural DNA but which 
have more stability or hydrophobicity to improve the properties of the conjugates. For 
example, the functionalization of the ends of single-walled carbon nanotubes was only 
successfully achieved by using PNA derivatives [17]. Conjugation of biotinylated-PNA 
to streptoavidin/ avidin nanoparticles results in formation of new drug derivatives for 
antisense therapy [18, 19] and improved detection at DNA-functionalized electrodes 
[20]. Recently, investigations of gold nanoparticles modified with PNA have shown 
that the PNA moiety can modulate the electrostatic surface properties and control 
nanoparticle assembly rates and aggregate size [21].  
In the present communication, we study the use of PNA and PNA-DNA chimeras 
for functionalization of the surface of citrate-stabilized gold nanoparticles. We show 
that the presence of a few negative charges are needed to stabilize the gold 
nanoparticles in solution and that PNA-DNA chimeras conjugated to gold nanoparticles 
remain stable after functionalization. The hybridisation and melting properties of 
complexes formed from chimera-nanoparticle conjugates and oligonucleotide-
nanoparticle conjugates are explored and sensitive mismatch discrimination, when the 
mismatch is located in the DNA part of the chimera, is demonstrated. 
Results and Discussion.- 1. Synthesis of Peptide Nucleic Acids and PNA-DNA 
chimeras carrying thiol groups. PNA sequence 1 (Table 1) was prepared by sequential 
addition of the commercially available Boc/Z PNA monomers as described elsewhere 
[22]. The progress of the coupling reactions was monitored by the ninhydrin test [23]. 
Cysteine protected with the p-methoxybenzoyl group was added at the N-terminal 
position to generate a free thiol group after removal of the protecting groups. The 
desired sequence was purified by HPLC. The same sequence but carrying three 
glutamic acid residues at the C-terminal position (sequence 2, Table 1) was prepared in 
a similar way. In this case the γ-carboxylic acid group of glutamic acid was protected 
with the 9-fluorenylmethyl (Fm) group that were removed with piperidine before the 
removal of the Z groups at the end of the synthesis.  
The synthesis of PNA-DNA chimeras 3 and 4 were performed using the 
methodology described previously [24-27]. In this strategy the monomethoxytrityl 
(MeOTr) group is used for the temporary protection of the backbone amino function 
and acyl protecting groups are used for the protection of the exocyclic amino functions 
of the nucleobases [24-27]. The MeOTr is removed under mild conditions (3% 
trichloroacetic acid in dichloromethane), and the nucleobase protecting groups are 
removed using concentrated aqueous ammonia. These conditions are similar to those 
employed in DNA synthesis allowing the preparation of molecules carrying both PNA 
and DNA moieties. The connexion of the PNA and the DNA part was done using a 
thymine PNA linker molecule carrying an OH protected with the MeOTr group [25, 27, 
28]. The oligonucleotide part was assembled on an automatic DNA synthesizer using 
standard protocols.  
 2. Synthesis and properties of oligonucleotide-gold nanoparticle conjugates.  
 Peptide Nucleic Acids, PNA-DNA chimeras and complementary oligonucleotides 
carrying thiol groups (1-10, Table 1) were reacted with citrate-stabilized gold 
nanoparticles (13 nm) to obtain gold nanoparticles with several oligonucleotide 
molecules per nanoparticle [7]. When gold nanoparticles were mixed with the all-PNA 
sequence 1 a precipitate was immediately formed indicating that the PNA molecules 
occupied the citrate binding sites and, as a result of the loss of surface negative charge, 
the nanoparticles were no longer stable in solution. When the reaction was performed 
with sequence 2 carrying the glutamic acid tail no precipitation was observed indicating 
that the glutamic acid tail prevented destabilization of the nanoparticles. However, 
when nanoparticles carrying sequence 2 were mixed with nanoparticles carrying the 
complementary sequence 10, no hybridization was observed. The expected red to blue 
color change that accompanies hybridization of oligonucleotide-nanoparticle conjugates 
[1] was not observed and the resulting solutions did not show any characteristic melting 
behavior when heated (followed by UV-visible absorption spectroscopy). By 
comparison the duplex formed by the same compounds without nanoparticles gave the 
expected melting profiles (data not shown) indicating that either surface 
functionalization of the gold nanoparticles with PNA 2 did not occur or, if it did occur, 
then the sequence was not accessible to hybridization. These results are in agreement 
with previously reported data [21].  
Consequently, the use of PNA-DNA chimeras for gold nanoparticle derivatisation was 
explored. Functionalization of citrate-stabilized gold nanoparticles with PNA-DNA 
chimeras was performed in the same manner as used for unmodified oligonucleotides. 
No aggregation of the conjugates that were formed was observed. The chimera-
nanoparticle conjugate 3 and complementary oligonucleotide-nanoparticle conjugate 4 
were then mixed together in equimolar amounts in hybridization buffer.  During the 
hybridization process the solution changes from an initial red color to a pale blue/black 
color. Oligonucleotide hybridisation results in the formation of 3D interlinked networks 
of nanoparticles. Significant spectral changes therefore occur in the UV-visible 
absorption spectra of these solutions due to the formation of nanoparticle aggregates 
following hybridization of the oligonucleotides or chimera-oligonucleotides. These 
large absorbance changes, as compared with unmodified oligonucleotides, are a result 
of the marked sensitivity of nanoparticle optical properties (especially the surface 
plasmon resonance) to the reduced internanoparticle distances that occur when the 
nanoparticles are brought into close proximity following hybridization [3,4,6-8]. The 
magnitude and reversibility of these spectral changes allows the progress of 
hybridization and subsequent denaturation to be monitored optically for very small 
oligonucleotide concentrations. 
 
The melting behaviour of the hybridized complex formed from chimera-nanoparticle 
conjugate 3 and complementary oligonucleotide-nanoparticle conjugate 6 was then 
studied. UV-visible absorption spectra were recorded as a function of increasing 
temperature. As the solution temperature increases, the oligonucleotide and chimera 
strands separate and hence the crosslinked nanoparticles also become separated and 
redisperse into solution causing a reversal of the spectral changes that occurred during 
hybridization [3,4,6-8]. Thus this melting transition represents the breakdown of the 3D 
interlinked gold nanoparticle networks following oligonucleotide-chimera complex 
denaturation.  Consequently, the melting profile of the hybridized complex formed from 
chimera-nanoparticle conjugate 3 and oligonucleotide-nanoparticle conjugate 6, shown 
in Figure 1, is distinct and well defined in comparison with the very poorly resolved 
melting profile acquired for the identical oligonucleotide-chimera complex formed 
without nanoparticle tags, also shown in Figure 1.  
 An interesting aspect of duplexes that incorporate PNA moieties is the low 
dependence of duplex stability on ionic strength. This is due to the elimination of the 
repulsion between phosphate groups in PNA/DNA duplexes. In our case, we employ 
DNA-PNA chimeras so the duplex will more closely resemble a DNA/DNA duplex. 
With respect to solution ionic strength, when chimera-nanoparticle conjugate 3 is mixed 
with complementary oligonucleotide-nanoparticle conjugate 6 in hybridization buffer 
containing 50 mM or 100 mM NaCl no color change associated with hybridization was 
observed and no melting transitions were observed on heating. This confirmed that a 
relatively high salt concentration is needed in the buffer in order to obtain chimera 
hybridisation, as in the case of DNA/DNA duplexes. 
The presence of base mismatches in oligonucleotide sequences was also studied. As 
can be seen from Figure 2 and Table 2 introduction of one mismatched base into 
chimera-nanoparticle and oligonucleotide-nanoparticle complexes resulted in the 
lowering of the melting temperature and the magnitude of the hyperchromic change 
associated with each melting transition. These effects were more pronounced when the 
mismatch was incorporated into the DNA part, where no transition at all was observed 
(duplexes 4 + 6 and 3 + 8). On the other hand, a mismatch within the PNA part (duplex 
3+7) gave the same melting profile as a mismatch within a DNA/DNA duplex (duplex 
5+7). It has been reported that mismatch discrimination is higher in PNA derivatives. 
For example, mismatches in PNA complexes have been reported to lower the melting 
temperature of duplexes by 8-20 ºC, twice that observed for mismatches in DNA/DNA 
duplexes [14]. Melting temperatures of PNA-DNA chimeras depend on various factors 
such as DNA:PNA ratio in the chimera, sequence, and the position of the linker 
molecule between DNA and PNA [16]. Our results show that, using PNA-DNA 
chimeras, it is possible to select a combination of conditions that eliminate 
hybridization with sequences carrying one single mismatch. We believe that these 
results will be of interest for mismatch detection in gene analysis using DNA 
microarrays [11, 12].  
 
Conclusion. In this study, PNA and PNA-DNA chimeras carrying thiol groups were 
used for surface functionalization of gold nanoparticles. We showed that citrate-
stabilized gold nanoparticles can be successfully functionalised with PNA-DNA 
chimeras and remain stable after functionalization. The hybridisation and melting 
properties of complexes formed from chimera-nanoparticle conjugates and 
oligonucleotide-nanoparticle conjugates are described for first time. Similar to 
oligonucleotide-gold nanoparticle conjugates, conjugates with PNA-DNA chimeras 
gave sharper and more defined melting profiles than those obtained for than unmodified 
oligonucleotides. In addition, mismatch discrimination was more efficient than with 
unmodified oligonucleotides  
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General. Phosphoramidites and ancillary reagents used during oligonucleotide synthesis 
were from Applied Biosystems (USA), Cruachem Ltd. (Scotland) and Glen Research 
(USA). PNA monomers protected with the Boc group were from Applied Biosystems 
(USA). Amino acid derivatives were from Bachem (Switzerland) and Novabiochem 
(Switzerland). The rest of the chemicals were purchased from Aldrich, Sigma or Fluka. 
Long chain amino controlled pore glass (LCA-CPG) was purchased from CPG Inc 
(USA). Amino-polyethyleneglycol-polystyrene (PEG-PS) was purchased from 
PerSeptive (now Applied Biosystems USA). Methylbenzhydrylamine-polystyrene 
support was from Novabiochem (Switzerland). Solvents were from S.D.S. (France). 
Gold nanoparticles (13 nm, citrate stabilized) were prepared as described elsewhere [7].  
Instrumentation. UV-visible absorption spectra were recorded on a UV-2103PC and 
Agilent 8453 spectrophotometers. Mass spectra (matrix-assisted laser desorption 
ionization time-of-flight, MALDI-TOF) were provided by the Mass spectrometry 
service at the University of Barcelona. DNA synthesis were performed on a 392 
Applied Biosystems (USA) DNA synthesizer. 
 
Synthesis of Peptide Nucleic Acids. PNA oligomer synthesis was carried out manually 
on a methylbenzhydrylamine (MBHA)-polystyrene support (5 µmol scale), following 
the synthesis cycle for the Boc/Z strategy described elsewhere [22]. The PNA 
monomers were added manually with a molar excess of 5 times activated by O-(7-
azabenzotriazol-1-yl)-1,1,3,3-tetramehtyluronium hexafluorophosphate (HATU) and 
diisoproyplethylamine (DIPEA). Coupling reaction was monitorized by the ninhydrin 
test [23], and the absence of color in the solution or resin beads indicated nearly 
quantitative yields (> 95%). For the introduction of cysteine Boc-Cys protected with the 
p-methoxybenzoyl group was used. The Fm group was used for the protection of the γ-
carboxylic group of glutamic acid. The last amino group was acetylated with acetic 
anhydride and diisopropylethylamine. After the completion of the sequence 2 the Fm 
group was removed with piperidine and the resulting support was treated with a mixture 
of trifluoroacetic acid and trifluoromethanesulfonic acid (using dimethylsulfide and m-
cresol as scavengers) as described [22]. The support from the synthesis of sequence 1 
was treated directly with a mixture of trifluoroacetic acid and trifluoromethanesulfonic 
acid and the scavengers. The resulting products were precipitated with ether and the 
residue was desalted with a Sephadex G-25 column (NAP-10, Pharmacia, Sweden). 
The PNA containing fractions were further purified by RP-HPLC obtaining the desired 
PNA oligomer. HPLC conditions. Column: Nucleosil 120 C18, (250x8 mm), flow rate 3 
ml/min, a 25 min gradient from 0% B to 50% B. Solution A: 5% acetonitrile in 0.1% 
trifluoroacetic acid in water. Solution B: 70% acetonitrile in 0.1% trifluoroacetic acid in 
water. Mass spectrometry confirmed that the desired product corresponded to the major 
peak on the chromatogram. MALDI-TOF of 1: 3306.9 ([M+H]+; calc for 
C131H168N66O38S: 3306.7). MALDI-TOF of 2: 3814.1 ([M+Na]+; calc for 
C150H194N70O49S: 3793.1). 
 Synthesis of PNA-DNA chimeras and oligonucleotides. 5’-Thiolated oligonucleotides 
were prepared using standard (benzoyl- or isobutyryl-protected) 3’-[(2’-
cyanoethyl)phosphoramidites] and the phosphoramidite of (MeO)2-Tr-protected 6-
hydroxyhexyl disulfide (Glen Research, USA).  
PNA-DNA chimeras were synthesized on a MeOTr-NH-hexyl-succinate-NH-PEG-PS-
support as described in reference [24]. PNA monomers were prepared as described [28]. 
PNA sequence TGCAT-CONH-hexyl-OH was synthesized on 10 µmol scale on a 
syringe equipped with a filter. The PNA monomers were added manually with a molar 
excess of 5 times. PNA monomer coupling was carried out adding equal amounts of 3 
solutions: a) 0.2 M PNA monomer in acetonitrile (T, G, A) or 0.1 M of the C monomer 
in dichloromethane (C), b) 0.2 M HATU in acetonitrile and c) 0.2 M DIPEA in ACN 
and a coupling time of 15 min. After coupling a capping with acetic anhydride and N-
methylimidazole was performed using the capping solutions from oligonucleotide 
synthesis and a capping time of 1 min. Deprotection of the monomethoxytrityl amino 
groups was carried out using 3% trichloroacetic acid in dichloromethane (10 x 1 ml, 5 
min) followed by thorough washing with acetonitrile, neutralization with 0.3 M DIPEA 
in acetonitrile and washing with acetonitrile. The last PNA monomer is a T-linker 
molecule carrying an OH protected with the MeOTr group [25, 27, 28]. The 
oligonucleotide part was assembled on an automatic DNA synthesizer using standard 2-
cyanoethyl phosphoramidites and following standard protocols (1 µmol scale). In order 
to characterize the PNA-support a short sequence of a DNA-PNA chimera was prepared 
(5’TGCAGCCTGCAT-CONH-hexyl-OH) and was purified by HPLC giving a major 
product that had the expected molecular weight. Electrospray of 5’TGCAGCCTGCAT-
CONH-hexyl-OH: 3611.0 ([M]; calc. for C127H166N53O60P7: 3611.4) 
The resulting supports were treated with 1ml of concentrated ammonia (overnight, 
55ºC). Supports carrying oligonucleotides and PNA-DNA chimeras with a thiol group 
at the 5’-end were treated overnight with 1ml of 50 mM dithio-DL-threitol (DTT) in 
concentrated ammonia at 55ºC. The excess of DTT was eliminated with a Sephadex G-
25 column (NAP-10, Pharmacia, Sweden) just prior to conjugation with gold 
nanoparticles.  
Dithiol linkages in thiolated oligonucleotide solutions were cleaved prior to use by 
adding an appropriate amount of 0.1 M solution of dithiothreitol (DTT) in 0.17 M 
sodium phosphate buffer (pH 8). Typically 20 µL of DTT solution was added to 100 µL 
of a 100 pmol/mL solution of the oligonucleotide. The solution was allowed to stand at 
room temperature for 0.5 h. The thiolated oligonucleotides were then desalted on a 
NAP-10 (Pharmacia) column using a 10 mM phosphate buffer (pH 7) as solvent. The 
optical absorbance at 260 nm of the purified oligonucleotide was used in conjunction 
with the known extinction co-efficient of the oligonucleotide to determine the 
oligonucleotide concentration according to Beer’s Law. Oligonucleotides were prepared 
for hybridisation experiments by dissolving them at appropriate concentration in buffer 
solution [0.3 M NaCl, 10 mM phosphate buffer, pH 7].  
 
Preparation of oligonucleotide-gold conjugates. Solutions of Au nanoparticles and 
oligonucleotides were mixed in appropriate amounts [29], i.e., 2.63 nmoles of 
oligonucleotide was used per mL of gold nanoparticles (the concentration of 
nanoparticles was 15.66 nM). The entire solution was then brought to 10 mM sodium 
phosphate buffer (pH 7). The amounts of reagents used in each conjugate synthesis 
included a 1.5 molar excess of oligonucleotide. After 24 hours, solutions were brought 
to 0.1 M NaCl concentration, by addition of the appropriate amount of a 1 M NaCl, 10 
mM sodium phosphate buffer solution (pH 7) and allowed to stand at room temperature 
for a further 40 hours. After this time, solutions were centrifuged at 13,200 rpm for 30 
min. The supernatant was removed and the reddish solid at the bottom of the tubes were 
dispersed in 0.1 M NaCl, 10 mM sodium phosphate buffer (pH 7) solution (the volume 
added was similar to that removed). This procedure was repeated and the reddish solid 
at the bottom of the centrifuge tubes were dispersed in 0.3 M NaCl, 10 mM sodium 
phosphate buffer (pH 7). Solutions were analyzed by UV-visible spectroscopy and 
absorbances at 260 nm and 520nm were recorded. The concentration of the conjugate 
solutions were determined using the absorbance of the solution at 520 nm and Beer’s 
Law [29]. Solutions were stored at room temperature. Hybridization experiments were 
carried out using 5 pmol amounts of each oligonucleotide-nanoparticle conjugate or 
chimera-nanoparticle conjugate (i.e., 0.32 nmoles of attached oligonucleotides) [30] in 
0.3 M NaCl, 10 mM phosphate buffer (pH 7) in a total reaction volume of 1 mL. The 
solutions were heated to 90 ºC for 5 min, slowly cooled to room temperature, and then 
left to hybridize for 24 h. 
 
Hybridization experiments. Oligonucleotide complexes were prepared by mixing 1 
nmol of each strand in a total reaction volume of 1 mL. The solutions were then heated 
to 90 °C for 5 min, slowly cooled to room temperature and left to hybridize for 24 h. 
Oligonucleotide-nanoparticle complexes were prepared by mixing 5 pmol of each 
oligonucleotide-nanoparticle conjugate and chimera-nanoparticle conjugate in 0.3 M 
NaCl, 10 mM sodium phosphate buffer, pH 7, in a total reaction volume of 1 mL. 
Hybridizations were also conducted in buffers containing 50 mM and 100 mM NaCl. 
The solutions were then heated to 90 ºC for 5 min, allowed to cool to room temperature 
and left to hybridize for 24 hours.  
 
Melting experiments. Optical melting curves were collected on a Agilent 8453 
spectrophotometer equipped with an Agilent temperature controlling Peltier unit. The 
prehybridized solution was transferred to a stoppered 1-cm path-length cuvette and UV-
visible optical absorption spectra were recorded at 2 ºC intervals, with a 1-2 minute 
heating time and a hold time of 1 minute at each temperature interval, while the sample 
was heated from 20 - 90 ºC. The data were collected as wavelength versus absorbance 
spectra from which plots of absorbance versus temperature at 260 nm were extracted. 
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 Table 1: Peptide nucleic acids, PNA-DNA chimeras and oligonucleotide sequences prepared in 
this work. Peptide nucleic acids are shown in italics. Ac: acetyl, Cys: cysteine, Glu: glutamic 
acid, Gly: glycine. Residues involved in mismatch are shown in bold. 
Compound Sequence 5’->3’ or N->C 
1, PNA H-Cys-ATGCTCAACTCT-CONH2 
2, PNA Ac-Cys-ATGCTCAACTCT-GluGluGluGly-CONH2 
3, PNA-DNA Thiol-hexyl-TCGACTATGCAT-CONH-hexyl-OH 
4, PNA-DNA MM Thiol-hexyl-TCGAGTATGCAT-CONH-hexyl-OH 
5, DNA Thiol-hexyl-TCGACTATGCAT 
6, DNA COMP Thiol-hexyl-ATGCATAGTCGA 
7, DNA MM1 Thiol-hexyl-ATCCATAGTCGA 
8, DNA MM2 Thiol-hexyl-ATGCATACTCGA 
9, DNA control Thiol-hexyl-GCTGTACAAGTA 
10, COMP TO 1 Thiol-hexyl-AGAGTTGAGCAT 
 
 Table 2: Melting characteristics of duplexes linked to gold nanoparticles. Experimental 
conditions: 0.3 M NaCl and 10 mM sodium phosphate pH 7. 
  
Sequences Type of duplex Duplex Tm(ºC), hyperchrom. 
5 + 6 DNA-DNA perfect match TCGACTATGCAT 
AGCTGATACGTA 
45 ºC, 50% 
3 + 6 DNA-CHIM perfect match TCGACTATGCAT 
AGCTGATACGTA 
40 ºC, 60% 
4 + 8 DNA-CHIM perfect match TCGAGTATGCAT 
AGCTCATACGTA 
38 ºC, 60% 
4 + 6 DNA-CHIM mismatch in DNA TCGAGTATGCAT 
AGCTGATACGTA 
No transition 
3 + 8 DNA-CHIM mismatch in DNA TCGACTATGCAT 
AGCTCATACGTA 
No transition 
3 + 7 DNA-CHIM mismatch in PNA TCGACTATGCAT 
AGCTGATACCTA 
35 ºC, 18% 
5 + 7 DNA-DNA mismatch TCGACTATGCAT 
AGCTGATACCTA 
35 ºC, 18% 
3 + 9 Control no complementary TCGACTATGCAT 
GCTGTACAAGTA 
No transition 
4 + 9 Control no complementary TCGAGTATGCAT 
GCTGTACAAGTA 
No transition 




 FIGURE LEGENDS 
 
Figure 1: Melting profiles at 260 nm of duplexes formed by a PNA-DNA chimera and the 
complementary DNA sequence. Duplexes are formed by mixing chimera-nanoparticle conjugate 
3 with complementary oligonucleotide-nanoparticle conjugate 6 (blue line) and chimera 3 with 
oligonucleotide 6 (red line).  
 
Figure 2: Effect of the mismatch on the melting profiles at 260 nm of duplexes formed by PNA-
DNA chimeras and their complementary DNA sequences. Both conjugates to Au nanoparticles. 
A) DNA/DNA perfect match (5-6). B) DNA/Chimera perfect match (4-8). C) DNA/Chimera 
mismatch in DNA part (3-8). D) DNA/Chimera mismatch in PNA part (3-7). Conditions: 0.3 M 
NaCl and 10 mM sodium phosphate pH 7. 
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